SCHEMBL13729690

SCHEMBL13729690

COc1cc(C(=O)NO)ncn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 5/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
STAT1 P42224 1/20 0.39
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HDAC1 Q13547 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HDAC3 O15379 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MMP13 P45452 1/20 0.38
HDAC2 Q92769 1/20 0.38
S1PR1 P21453 3/20 0.37
HDAC8 Q9BY41 2/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3716193 0.81 ALDH1A1 (0.48) LMNATDP1ALDH1A1KDM4ENNMT
SCHEMBL20869196 0.79 LMNA (0.42) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL9190690 0.79 LMNA (0.55) LMNATDP1ALDH1A1KDM4ENNMT
SCHEMBL13726677 0.78 SIRT6 (0.55) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL22256527 0.74 GSK3B (0.40) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL16319054 0.72 NPC1 (0.38) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL22256522 0.72 LMNA (0.37) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL22121995 0.72 CYP2C19 (0.38) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL30103450 0.72 LMNA (0.38) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL15508132 0.71 LMNA (0.39) NPC1RAB9ASMN1; SMN2TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012151567-A1 PYRIMIDINONE COMPOUNDS AND METHODS FOR PREVENTING AND TREATING INFLUENZA ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2012-11-08 WO disclosed